|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:LNPEP-PPIP5K2 (FusionGDB2 ID:45868) |
Fusion Gene Summary for LNPEP-PPIP5K2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: LNPEP-PPIP5K2 | Fusion gene ID: 45868 | Hgene | Tgene | Gene symbol | LNPEP | PPIP5K2 | Gene ID | 4012 | 23262 |
Gene name | leucyl and cystinyl aminopeptidase | diphosphoinositol pentakisphosphate kinase 2 | |
Synonyms | CAP|IRAP|P-LAP|PLAP | CFAP160|DFNB100|HISPPD1|IP7K2|VIP2 | |
Cytomap | 5q15 | 5q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | leucyl-cystinyl aminopeptidaseAT (4) receptorangiotensin IV receptorcystinyl aminopeptidaseinsulin-regulated aminopeptidaseinsulin-regulated membrane aminopeptidaseinsulin-responsive aminopeptidaseotaseoxytocinaseplacental leucine aminopeptidase | inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2VIP1 homolog 2deafness, autosomal recessive 100histidine acid phosphatase domain-containing protein 1inositol heptaphosphate kinase 2insP6 and PP-IP5 kinase 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9UIQ6 | . | |
Ensembl transtripts involved in fusion gene | ENST00000231368, ENST00000395770, ENST00000395784, | ENST00000414217, ENST00000513500, ENST00000321521, ENST00000358359, | |
Fusion gene scores | * DoF score | 9 X 8 X 6=432 | 5 X 6 X 3=90 |
# samples | 10 | 5 | |
** MAII score | log2(10/432*10)=-2.11103131238874 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/90*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LNPEP [Title/Abstract] AND PPIP5K2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | LNPEP(96322374)-PPIP5K2(102537222), # samples:2 LNPEP(96322374)-PPIP5K2(102537223), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | LNPEP-PPIP5K2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. LNPEP-PPIP5K2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. LNPEP-PPIP5K2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across LNPEP (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PPIP5K2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-XK-AAJ3-01A | LNPEP | chr5 | 96322374 | - | PPIP5K2 | chr5 | 102537223 | + |
ChimerDB4 | PRAD | TCGA-XK-AAJ3 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
ChimerDB4 | PRAD | TCGA-XK-AAJ3 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
Top |
Fusion Gene ORF analysis for LNPEP-PPIP5K2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000231368 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
5CDS-3UTR | ENST00000231368 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
5CDS-3UTR | ENST00000231368 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
5CDS-3UTR | ENST00000231368 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
5CDS-3UTR | ENST00000395770 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
5CDS-3UTR | ENST00000395770 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
5CDS-3UTR | ENST00000395770 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
5CDS-3UTR | ENST00000395770 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
Frame-shift | ENST00000231368 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
Frame-shift | ENST00000231368 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
Frame-shift | ENST00000395770 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
Frame-shift | ENST00000395770 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
In-frame | ENST00000231368 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
In-frame | ENST00000231368 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
In-frame | ENST00000395770 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
In-frame | ENST00000395770 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
intron-3CDS | ENST00000395784 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
intron-3CDS | ENST00000395784 | ENST00000321521 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
intron-3CDS | ENST00000395784 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
intron-3CDS | ENST00000395784 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
intron-3UTR | ENST00000395784 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
intron-3UTR | ENST00000395784 | ENST00000414217 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
intron-3UTR | ENST00000395784 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + |
intron-3UTR | ENST00000395784 | ENST00000513500 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000231368 | LNPEP | chr5 | 96322374 | + | ENST00000358359 | PPIP5K2 | chr5 | 102537222 | + | 3508 | 1823 | 491 | 1882 | 463 |
ENST00000395770 | LNPEP | chr5 | 96322374 | + | ENST00000358359 | PPIP5K2 | chr5 | 102537222 | + | 3123 | 1438 | 229 | 1497 | 422 |
ENST00000231368 | LNPEP | chr5 | 96322374 | + | ENST00000358359 | PPIP5K2 | chr5 | 102537223 | + | 3508 | 1823 | 491 | 1882 | 463 |
ENST00000395770 | LNPEP | chr5 | 96322374 | + | ENST00000358359 | PPIP5K2 | chr5 | 102537223 | + | 3123 | 1438 | 229 | 1497 | 422 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000231368 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + | 0.000130139 | 0.9998698 |
ENST00000395770 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + | 0.000342403 | 0.99965763 |
ENST00000231368 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + | 0.000130139 | 0.9998698 |
ENST00000395770 | ENST00000358359 | LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537223 | + | 0.000342403 | 0.99965763 |
Top |
Fusion Genomic Features for LNPEP-PPIP5K2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + | 1.45E-07 | 0.9999999 |
LNPEP | chr5 | 96322374 | + | PPIP5K2 | chr5 | 102537222 | + | 1.45E-07 | 0.9999999 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for LNPEP-PPIP5K2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:96322374/chr5:102537222) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
LNPEP | . |
FUNCTION: Release of an N-terminal amino acid, cleaves before cysteine, leucine as well as other amino acids. Degrades peptide hormones such as oxytocin, vasopressin and angiotensin III, and plays a role in maintaining homeostasis during pregnancy. May be involved in the inactivation of neuronal peptides in the brain. Cleaves Met-enkephalin and dynorphin. Binds angiotensin IV and may be the angiotensin IV receptor in the brain. {ECO:0000269|PubMed:11389728, ECO:0000269|PubMed:11707427, ECO:0000269|PubMed:1731608}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 53_54 | 377 | 1026.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 76_77 | 377 | 1026.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 53_54 | 363 | 1012.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 76_77 | 363 | 1012.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 53_54 | 377 | 1026.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 76_77 | 377 | 1026.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 53_54 | 363 | 1012.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 76_77 | 363 | 1012.0 | Motif | Dileucine internalization motif |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 96_101 | 377 | 1026.0 | Region | Note=Tankyrase binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 96_101 | 363 | 1012.0 | Region | Note=Tankyrase binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 96_101 | 377 | 1026.0 | Region | Note=Tankyrase binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 96_101 | 363 | 1012.0 | Region | Note=Tankyrase binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 1_110 | 377 | 1026.0 | Topological domain | Cytoplasmic |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 1_110 | 363 | 1012.0 | Topological domain | Cytoplasmic |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 1_110 | 377 | 1026.0 | Topological domain | Cytoplasmic |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 1_110 | 363 | 1012.0 | Topological domain | Cytoplasmic |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 111_131 | 377 | 1026.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 111_131 | 363 | 1012.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 111_131 | 377 | 1026.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 111_131 | 363 | 1012.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 428_432 | 377 | 1026.0 | Region | Substrate binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 428_432 | 363 | 1012.0 | Region | Substrate binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 428_432 | 377 | 1026.0 | Region | Substrate binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 428_432 | 363 | 1012.0 | Region | Substrate binding |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000231368 | + | 4 | 18 | 132_1025 | 377 | 1026.0 | Topological domain | Extracellular |
Hgene | LNPEP | chr5:96322374 | chr5:102537222 | ENST00000395770 | + | 4 | 18 | 132_1025 | 363 | 1012.0 | Topological domain | Extracellular |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000231368 | + | 4 | 18 | 132_1025 | 377 | 1026.0 | Topological domain | Extracellular |
Hgene | LNPEP | chr5:96322374 | chr5:102537223 | ENST00000395770 | + | 4 | 18 | 132_1025 | 363 | 1012.0 | Topological domain | Extracellular |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 237_240 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 246_248 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 321_323 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 237_240 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 246_248 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 321_323 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 237_240 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 246_248 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 321_323 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 237_240 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 246_248 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 321_323 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 237_240 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 246_248 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 321_323 | 1206 | 1244.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 237_240 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 246_248 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 321_323 | 1185 | 1223.0 | Nucleotide binding | ATP | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 213_214 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 326_329 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 371_442 | 1185 | 1223.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000321521 | 28 | 30 | 53_54 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 213_214 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 326_329 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 371_442 | 1206 | 1244.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000358359 | 29 | 31 | 53_54 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 213_214 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 326_329 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 371_442 | 1185 | 1223.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537222 | ENST00000414217 | 27 | 29 | 53_54 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 213_214 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 326_329 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 371_442 | 1185 | 1223.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000321521 | 28 | 30 | 53_54 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 213_214 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 326_329 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 371_442 | 1206 | 1244.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000358359 | 29 | 31 | 53_54 | 1206 | 1244.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 213_214 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 326_329 | 1185 | 1223.0 | Region | Substrate binding | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 371_442 | 1185 | 1223.0 | Region | Polyphosphoinositide-binding domain | |
Tgene | PPIP5K2 | chr5:96322374 | chr5:102537223 | ENST00000414217 | 27 | 29 | 53_54 | 1185 | 1223.0 | Region | Substrate binding |
Top |
Fusion Gene Sequence for LNPEP-PPIP5K2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>45868_45868_1_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000231368_PPIP5K2_chr5_102537222_ENST00000358359_length(transcript)=3508nt_BP=1823nt TCCGCGGCCAACCTCCCCAGGGAAACCAGCGATTCGCGGTTCAGATAGCGACCTTCGCCCGCAGGTTCCTGCTCTGCCTTCAGACTTCGG CTTCAGTGGCACCTGCTCAGCGAGGCCTCGTCTAACCAAGCCATCCGAATTAACTACCCACTCACTCGCCATCACATCACCCCGATTTAA TTCGCAGCGGGGCACTGACTTTACACTCGTGTGTCTTCTGTGTTTATTTATGGTCTGTTTCTGGAATGTCCGCTCCTGGGACTGGGACCA TGATTTTCTGGCGCAGTGCGGGTGTCTCGGCGTCCGGGATCGGGCGGGTCGCAGTAGGGCTCCACATTTGTTGAGTGACTGAACACCGTT CCCGGCCGGGGAGAGCGCCGCAGCCGGGTCCACTTCAGGTAGGGGCTGGGCTTTCCCGGCCCCGCCTAGGCCCCGCCCCCAGCGCGAACC CGCTCCCACCTCGCCTGTCCACGGAGCAGCAGGGGGTTTGACTGTGCTTTTCCCTCTTGCTTCCCTCGCTCTTTCTGCAGCTGCCACGAA AACCCGGAACGGCGGAGCGGCGCCGCCCCTCGCGGCACCTCCCTGGCAGCCCTTGGAGGCCGCGCTGGGCATGCTCAGTCAGCTGGGCCG CCTCAGCTCTCGGAGTAGGAAGCTCGGGCGCTCCGGCTGTAAGGAGCCGCGGCGGGGGGAAAATGGAGCCCTTCACCAATGATCGGCTTC AGCTCCCCAGGAATATGATTGAAAACAGCATGTTTGAGGAAGAACCAGATGTGGTGGATTTAGCCAAAGAGCCTTGTTTACATCCTCTAG AGCCTGATGAGGTGGAATATGAGCCCCGGGGTTCCCGACTGCTGGTGCGGGGTCTTGGTGAGCATGAGATGGAGGAGGATGAAGAGGATT ATGAGTCATCAGCAAAGCTGCTGGGCATGTCCTTCATGAATAGAAGCTCAGGCCTTCGGAACAGTGCAACTGGTTACAGGCAGAGCCCAG ATGGGGCTTGTTCAGTACCCTCTGCAAGGACCATGGTGGTCTGTGCTTTTGTCATCGTGGTTGCTGTTTCTGTAATCATGGTGATTTACT TACTGCCCAGATGTACCTTTACCAAAGAAGGCTGCCATAAAAAAAACCAGTCAATTGGACTAATTCAGCCATTTGCAACAAATGGGAAAT TGTTTCCATGGGCACAGATCAGGCTTCCCACTGCCGTTGTGCCACTACGCTATGAACTCAGCCTACACCCGAACCTAACCTCGATGACAT TCAGGGGTTCTGTGACAATTTCAGTTCAGGCTCTTCAGGTCACATGGAATATCATTCTTCATAGCACAGGTCATAATATTTCAAGAGTGA CCTTTATGTCAGCAGTTTCAAGCCAAGAAAAACAAGCTGAGATCCTGGAATATGCATATCATGGACAGATCGCCATTGTTGCCCCCGAAG CCCTTCTAGCAGGGCACAATTATACGTTGAAGATAGAGTACTCGGCAAATATATCTAGTTCTTATTATGGGTTTTATGGCTTCTCCTACA CAGATGAAAGTAATGAGAAAAAGTACTTTGCAGCAACTCAGTTTGAACCCCTGGCAGCAAGATCTGCTTTTCCTTGTTTTGATGAACCAG CATTTAAAGCCACTTTTATCATCAAGATCATAAGGGATGAGCAATACACCGCTTTATCAAATATGCCTAAGAAGTCATCAGTCGTTCTAG ATGATGGACTTGTTCAGGATGAGTTTTCTGAGAGTGTGAAGATGAGCACTTACTTGGTTGCTTTCATTGTGGGAGAGATGAAGAACCTGA GTCAGGACGTAAATGGAACCCTGCTACAAGTGGACCTTCTAGTGCAGTTGTTCCTAATACCTCATCTCGGAAAAAGAATATAACTAGCAA AACAGAAACGCATGAACACAAAAAAAACACTGGGAAAAAGAAATGAAATCTTAGCAGAAGCTGGAACTTTTTATACTTATAAAAATAGTA TGTTCTTATGTTTCTCCTTATGCATTTATGTGTTCACTTAAAAATGTTTTTAAATCTAAGGTTTTCTTTGTTTATGTTCAGGTAAGGAAC TGTTGTCATGATCTGGAAATGTTTAAAACAATGTTTGTTAGCATTCTGTGAGCAGCAAAACTTATAGTGATAAAAATCGATTGTTGTTAA TATGATGTTTACCATGTGCACATAGTAATGAAAAGGAACATAAAAGCCCAGCAGGCTCGTACCAAAGTCACAGCAGTAATGCTATGTACT GCAGAGTCTGATGAGCTGGCCTTTGTGCACACTTTTATTTTCATGGGATTGCATCTTAGCTGTTAAAACTTCTAGATTGAAATTTGACAG CCAGGGTTACATATTGGGGACTTTTAAAGTGTCTTTCCAAAGAGATTTCATTAACCGTTTAGATTAGAATATCTTTCCCAATTGTTACAG TGACATATATGCTGCAATATTTAACAACTGGAGTATTAGCCACATGGGTTATTTTTTCAATCTGTGTTTTGAATTTTTTTATTGTGTGTT ATTTAAAATATTACATATGCAGCTGGGAGAACTACACCTTTGTGCACATAGATTTATATATTAATTTGTAGAAAATATTTTCTTTATATA TTTCCTTACCATACAAGGTGCCTTGTTCATCAGGAAAACTTTTGTTTTGTATTTTGACAAGAAAGGCACCTTCAGAGTTTCTTTTTAAGT ATAGTTGACAAGTGTATAAATGTTACACTTACTTTCAGAGTTCTTTTTAGATCTAAAGAAGTCAGTTCAAAAATGGAAATCAACAATGTT AGGAGAAATCTGAATTCTGTTAAGTTAGTAAGTATTATGTATAGCATCTGTTTTTAACCATTTCCATTCTTATCCCTAGTGTATCAGTTG ATCACACTAAGAAAGCTTAAAGATTGAGCATTTGAAATAAATGCTCTTTATAAATGATTAGATTTTTGAAGGGATATTGAAATCATTGCG CTGTGATTTCATCTGTGATGTGAAAAATCAATTTATTATCCTTGGTGCTTTCCCCCCCACCAATGCACAAATAATTGTGAACAGCTTGAA ATGACTTAAACTGTAATCCAAATGGGACAATCTGATAAGAATTTCATGCATTGGTAGTTAAATAACTTAAATTGCTAAAGCTTTAGCTTG AAATTTATGTTTAGAAAAACTATTGATTTCCCATGGTATGAATATAACTATTGTAATTCTTCAAATGAGACTCTTCTCACCTTAAATAGT CATATATTAATTAACTTATAGGAAATAAGCATACTATATGTTAGCTGTTTTAAAAGGTACCAGATGTAAGAGTCATAAATATATGCAATT AAAGAAGTTCATAGATTTCACATGAATGTAAATGTGTTATATGGAGACATGTCTTGTAAACAGTTGAATGTATGTAAGTTTTCTGTTTGT >45868_45868_1_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000231368_PPIP5K2_chr5_102537222_ENST00000358359_length(amino acids)=463AA_BP=444 MCFSLLLPSLFLQLPRKPGTAERRRPSRHLPGSPWRPRWACSVSWAASALGVGSSGAPAVRSRGGGKMEPFTNDRLQLPRNMIENSMFEE EPDVVDLAKEPCLHPLEPDEVEYEPRGSRLLVRGLGEHEMEEDEEDYESSAKLLGMSFMNRSSGLRNSATGYRQSPDGACSVPSARTMVV CAFVIVVAVSVIMVIYLLPRCTFTKEGCHKKNQSIGLIQPFATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQV TWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQ FEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLLQVDLL -------------------------------------------------------------- >45868_45868_2_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000231368_PPIP5K2_chr5_102537223_ENST00000358359_length(transcript)=3508nt_BP=1823nt TCCGCGGCCAACCTCCCCAGGGAAACCAGCGATTCGCGGTTCAGATAGCGACCTTCGCCCGCAGGTTCCTGCTCTGCCTTCAGACTTCGG CTTCAGTGGCACCTGCTCAGCGAGGCCTCGTCTAACCAAGCCATCCGAATTAACTACCCACTCACTCGCCATCACATCACCCCGATTTAA TTCGCAGCGGGGCACTGACTTTACACTCGTGTGTCTTCTGTGTTTATTTATGGTCTGTTTCTGGAATGTCCGCTCCTGGGACTGGGACCA TGATTTTCTGGCGCAGTGCGGGTGTCTCGGCGTCCGGGATCGGGCGGGTCGCAGTAGGGCTCCACATTTGTTGAGTGACTGAACACCGTT CCCGGCCGGGGAGAGCGCCGCAGCCGGGTCCACTTCAGGTAGGGGCTGGGCTTTCCCGGCCCCGCCTAGGCCCCGCCCCCAGCGCGAACC CGCTCCCACCTCGCCTGTCCACGGAGCAGCAGGGGGTTTGACTGTGCTTTTCCCTCTTGCTTCCCTCGCTCTTTCTGCAGCTGCCACGAA AACCCGGAACGGCGGAGCGGCGCCGCCCCTCGCGGCACCTCCCTGGCAGCCCTTGGAGGCCGCGCTGGGCATGCTCAGTCAGCTGGGCCG CCTCAGCTCTCGGAGTAGGAAGCTCGGGCGCTCCGGCTGTAAGGAGCCGCGGCGGGGGGAAAATGGAGCCCTTCACCAATGATCGGCTTC AGCTCCCCAGGAATATGATTGAAAACAGCATGTTTGAGGAAGAACCAGATGTGGTGGATTTAGCCAAAGAGCCTTGTTTACATCCTCTAG AGCCTGATGAGGTGGAATATGAGCCCCGGGGTTCCCGACTGCTGGTGCGGGGTCTTGGTGAGCATGAGATGGAGGAGGATGAAGAGGATT ATGAGTCATCAGCAAAGCTGCTGGGCATGTCCTTCATGAATAGAAGCTCAGGCCTTCGGAACAGTGCAACTGGTTACAGGCAGAGCCCAG ATGGGGCTTGTTCAGTACCCTCTGCAAGGACCATGGTGGTCTGTGCTTTTGTCATCGTGGTTGCTGTTTCTGTAATCATGGTGATTTACT TACTGCCCAGATGTACCTTTACCAAAGAAGGCTGCCATAAAAAAAACCAGTCAATTGGACTAATTCAGCCATTTGCAACAAATGGGAAAT TGTTTCCATGGGCACAGATCAGGCTTCCCACTGCCGTTGTGCCACTACGCTATGAACTCAGCCTACACCCGAACCTAACCTCGATGACAT TCAGGGGTTCTGTGACAATTTCAGTTCAGGCTCTTCAGGTCACATGGAATATCATTCTTCATAGCACAGGTCATAATATTTCAAGAGTGA CCTTTATGTCAGCAGTTTCAAGCCAAGAAAAACAAGCTGAGATCCTGGAATATGCATATCATGGACAGATCGCCATTGTTGCCCCCGAAG CCCTTCTAGCAGGGCACAATTATACGTTGAAGATAGAGTACTCGGCAAATATATCTAGTTCTTATTATGGGTTTTATGGCTTCTCCTACA CAGATGAAAGTAATGAGAAAAAGTACTTTGCAGCAACTCAGTTTGAACCCCTGGCAGCAAGATCTGCTTTTCCTTGTTTTGATGAACCAG CATTTAAAGCCACTTTTATCATCAAGATCATAAGGGATGAGCAATACACCGCTTTATCAAATATGCCTAAGAAGTCATCAGTCGTTCTAG ATGATGGACTTGTTCAGGATGAGTTTTCTGAGAGTGTGAAGATGAGCACTTACTTGGTTGCTTTCATTGTGGGAGAGATGAAGAACCTGA GTCAGGACGTAAATGGAACCCTGCTACAAGTGGACCTTCTAGTGCAGTTGTTCCTAATACCTCATCTCGGAAAAAGAATATAACTAGCAA AACAGAAACGCATGAACACAAAAAAAACACTGGGAAAAAGAAATGAAATCTTAGCAGAAGCTGGAACTTTTTATACTTATAAAAATAGTA TGTTCTTATGTTTCTCCTTATGCATTTATGTGTTCACTTAAAAATGTTTTTAAATCTAAGGTTTTCTTTGTTTATGTTCAGGTAAGGAAC TGTTGTCATGATCTGGAAATGTTTAAAACAATGTTTGTTAGCATTCTGTGAGCAGCAAAACTTATAGTGATAAAAATCGATTGTTGTTAA TATGATGTTTACCATGTGCACATAGTAATGAAAAGGAACATAAAAGCCCAGCAGGCTCGTACCAAAGTCACAGCAGTAATGCTATGTACT GCAGAGTCTGATGAGCTGGCCTTTGTGCACACTTTTATTTTCATGGGATTGCATCTTAGCTGTTAAAACTTCTAGATTGAAATTTGACAG CCAGGGTTACATATTGGGGACTTTTAAAGTGTCTTTCCAAAGAGATTTCATTAACCGTTTAGATTAGAATATCTTTCCCAATTGTTACAG TGACATATATGCTGCAATATTTAACAACTGGAGTATTAGCCACATGGGTTATTTTTTCAATCTGTGTTTTGAATTTTTTTATTGTGTGTT ATTTAAAATATTACATATGCAGCTGGGAGAACTACACCTTTGTGCACATAGATTTATATATTAATTTGTAGAAAATATTTTCTTTATATA TTTCCTTACCATACAAGGTGCCTTGTTCATCAGGAAAACTTTTGTTTTGTATTTTGACAAGAAAGGCACCTTCAGAGTTTCTTTTTAAGT ATAGTTGACAAGTGTATAAATGTTACACTTACTTTCAGAGTTCTTTTTAGATCTAAAGAAGTCAGTTCAAAAATGGAAATCAACAATGTT AGGAGAAATCTGAATTCTGTTAAGTTAGTAAGTATTATGTATAGCATCTGTTTTTAACCATTTCCATTCTTATCCCTAGTGTATCAGTTG ATCACACTAAGAAAGCTTAAAGATTGAGCATTTGAAATAAATGCTCTTTATAAATGATTAGATTTTTGAAGGGATATTGAAATCATTGCG CTGTGATTTCATCTGTGATGTGAAAAATCAATTTATTATCCTTGGTGCTTTCCCCCCCACCAATGCACAAATAATTGTGAACAGCTTGAA ATGACTTAAACTGTAATCCAAATGGGACAATCTGATAAGAATTTCATGCATTGGTAGTTAAATAACTTAAATTGCTAAAGCTTTAGCTTG AAATTTATGTTTAGAAAAACTATTGATTTCCCATGGTATGAATATAACTATTGTAATTCTTCAAATGAGACTCTTCTCACCTTAAATAGT CATATATTAATTAACTTATAGGAAATAAGCATACTATATGTTAGCTGTTTTAAAAGGTACCAGATGTAAGAGTCATAAATATATGCAATT AAAGAAGTTCATAGATTTCACATGAATGTAAATGTGTTATATGGAGACATGTCTTGTAAACAGTTGAATGTATGTAAGTTTTCTGTTTGT >45868_45868_2_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000231368_PPIP5K2_chr5_102537223_ENST00000358359_length(amino acids)=463AA_BP=444 MCFSLLLPSLFLQLPRKPGTAERRRPSRHLPGSPWRPRWACSVSWAASALGVGSSGAPAVRSRGGGKMEPFTNDRLQLPRNMIENSMFEE EPDVVDLAKEPCLHPLEPDEVEYEPRGSRLLVRGLGEHEMEEDEEDYESSAKLLGMSFMNRSSGLRNSATGYRQSPDGACSVPSARTMVV CAFVIVVAVSVIMVIYLLPRCTFTKEGCHKKNQSIGLIQPFATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQV TWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQ FEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLLQVDLL -------------------------------------------------------------- >45868_45868_3_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000395770_PPIP5K2_chr5_102537222_ENST00000358359_length(transcript)=3123nt_BP=1438nt GCTCCTAACTCCACTAAGTACAGAAGTGGAGCCGTACAGCCATGAATGTCAGGCATGTTGTGGGGACTAGTTGTATTAGTTTTCTATTGC CACCATAACAAATTACCACAAACTTAAGCAATATAGTACAAATTTATCTTAAAGTTATTGGCAGGTCAGAAGCCTGATACGGATCTCATT GGGCTAAAACGAAGGAGTTGGCAGGGCTGTGTGTTCCTTTCTGTAGGCTCTGGGCAGGATCCATTTCCTGCACTTTTTTGGCTTTTGGAG GTCGTCCACATTCCTTGGCTCCTGGCCCTGCTCCTTCATCTTCAAAGCTACCAAAGATCGGCTTCAGCTCCCCAGGAATATGATTGAAAA CAGCATGTTTGAGGAAGAACCAGATGTGGTGGATTTAGCCAAAGAGCCTTGTTTACATCCTCTAGAGCCTGATGAGGTGGAATATGAGCC CCGGGGTTCCCGACTGCTGGTGCGGGGTCTTGGTGAGCATGAGATGGAGGAGGATGAAGAGGATTATGAGTCATCAGCAAAGCTGCTGGG CATGTCCTTCATGAATAGAAGCTCAGGCCTTCGGAACAGTGCAACTGGTTACAGGCAGAGCCCAGATGGGGCTTGTTCAGTACCCTCTGC AAGGACCATGGTGGTCTGTGCTTTTGTCATCGTGGTTGCTGTTTCTGTAATCATGGTGATTTACTTACTGCCCAGATGTACCTTTACCAA AGAAGGCTGCCATAAAAAAAACCAGTCAATTGGACTAATTCAGCCATTTGCAACAAATGGGAAATTGTTTCCATGGGCACAGATCAGGCT TCCCACTGCCGTTGTGCCACTACGCTATGAACTCAGCCTACACCCGAACCTAACCTCGATGACATTCAGGGGTTCTGTGACAATTTCAGT TCAGGCTCTTCAGGTCACATGGAATATCATTCTTCATAGCACAGGTCATAATATTTCAAGAGTGACCTTTATGTCAGCAGTTTCAAGCCA AGAAAAACAAGCTGAGATCCTGGAATATGCATATCATGGACAGATCGCCATTGTTGCCCCCGAAGCCCTTCTAGCAGGGCACAATTATAC GTTGAAGATAGAGTACTCGGCAAATATATCTAGTTCTTATTATGGGTTTTATGGCTTCTCCTACACAGATGAAAGTAATGAGAAAAAGTA CTTTGCAGCAACTCAGTTTGAACCCCTGGCAGCAAGATCTGCTTTTCCTTGTTTTGATGAACCAGCATTTAAAGCCACTTTTATCATCAA GATCATAAGGGATGAGCAATACACCGCTTTATCAAATATGCCTAAGAAGTCATCAGTCGTTCTAGATGATGGACTTGTTCAGGATGAGTT TTCTGAGAGTGTGAAGATGAGCACTTACTTGGTTGCTTTCATTGTGGGAGAGATGAAGAACCTGAGTCAGGACGTAAATGGAACCCTGCT ACAAGTGGACCTTCTAGTGCAGTTGTTCCTAATACCTCATCTCGGAAAAAGAATATAACTAGCAAAACAGAAACGCATGAACACAAAAAA AACACTGGGAAAAAGAAATGAAATCTTAGCAGAAGCTGGAACTTTTTATACTTATAAAAATAGTATGTTCTTATGTTTCTCCTTATGCAT TTATGTGTTCACTTAAAAATGTTTTTAAATCTAAGGTTTTCTTTGTTTATGTTCAGGTAAGGAACTGTTGTCATGATCTGGAAATGTTTA AAACAATGTTTGTTAGCATTCTGTGAGCAGCAAAACTTATAGTGATAAAAATCGATTGTTGTTAATATGATGTTTACCATGTGCACATAG TAATGAAAAGGAACATAAAAGCCCAGCAGGCTCGTACCAAAGTCACAGCAGTAATGCTATGTACTGCAGAGTCTGATGAGCTGGCCTTTG TGCACACTTTTATTTTCATGGGATTGCATCTTAGCTGTTAAAACTTCTAGATTGAAATTTGACAGCCAGGGTTACATATTGGGGACTTTT AAAGTGTCTTTCCAAAGAGATTTCATTAACCGTTTAGATTAGAATATCTTTCCCAATTGTTACAGTGACATATATGCTGCAATATTTAAC AACTGGAGTATTAGCCACATGGGTTATTTTTTCAATCTGTGTTTTGAATTTTTTTATTGTGTGTTATTTAAAATATTACATATGCAGCTG GGAGAACTACACCTTTGTGCACATAGATTTATATATTAATTTGTAGAAAATATTTTCTTTATATATTTCCTTACCATACAAGGTGCCTTG TTCATCAGGAAAACTTTTGTTTTGTATTTTGACAAGAAAGGCACCTTCAGAGTTTCTTTTTAAGTATAGTTGACAAGTGTATAAATGTTA CACTTACTTTCAGAGTTCTTTTTAGATCTAAAGAAGTCAGTTCAAAAATGGAAATCAACAATGTTAGGAGAAATCTGAATTCTGTTAAGT TAGTAAGTATTATGTATAGCATCTGTTTTTAACCATTTCCATTCTTATCCCTAGTGTATCAGTTGATCACACTAAGAAAGCTTAAAGATT GAGCATTTGAAATAAATGCTCTTTATAAATGATTAGATTTTTGAAGGGATATTGAAATCATTGCGCTGTGATTTCATCTGTGATGTGAAA AATCAATTTATTATCCTTGGTGCTTTCCCCCCCACCAATGCACAAATAATTGTGAACAGCTTGAAATGACTTAAACTGTAATCCAAATGG GACAATCTGATAAGAATTTCATGCATTGGTAGTTAAATAACTTAAATTGCTAAAGCTTTAGCTTGAAATTTATGTTTAGAAAAACTATTG ATTTCCCATGGTATGAATATAACTATTGTAATTCTTCAAATGAGACTCTTCTCACCTTAAATAGTCATATATTAATTAACTTATAGGAAA TAAGCATACTATATGTTAGCTGTTTTAAAAGGTACCAGATGTAAGAGTCATAAATATATGCAATTAAAGAAGTTCATAGATTTCACATGA ATGTAAATGTGTTATATGGAGACATGTCTTGTAAACAGTTGAATGTATGTAAGTTTTCTGTTTGTGAAAATGTAGTTAATGTACTCACTG >45868_45868_3_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000395770_PPIP5K2_chr5_102537222_ENST00000358359_length(amino acids)=422AA_BP=403 MGRIHFLHFFGFWRSSTFLGSWPCSFIFKATKDRLQLPRNMIENSMFEEEPDVVDLAKEPCLHPLEPDEVEYEPRGSRLLVRGLGEHEME EDEEDYESSAKLLGMSFMNRSSGLRNSATGYRQSPDGACSVPSARTMVVCAFVIVVAVSVIMVIYLLPRCTFTKEGCHKKNQSIGLIQPF ATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIA IVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK -------------------------------------------------------------- >45868_45868_4_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000395770_PPIP5K2_chr5_102537223_ENST00000358359_length(transcript)=3123nt_BP=1438nt GCTCCTAACTCCACTAAGTACAGAAGTGGAGCCGTACAGCCATGAATGTCAGGCATGTTGTGGGGACTAGTTGTATTAGTTTTCTATTGC CACCATAACAAATTACCACAAACTTAAGCAATATAGTACAAATTTATCTTAAAGTTATTGGCAGGTCAGAAGCCTGATACGGATCTCATT GGGCTAAAACGAAGGAGTTGGCAGGGCTGTGTGTTCCTTTCTGTAGGCTCTGGGCAGGATCCATTTCCTGCACTTTTTTGGCTTTTGGAG GTCGTCCACATTCCTTGGCTCCTGGCCCTGCTCCTTCATCTTCAAAGCTACCAAAGATCGGCTTCAGCTCCCCAGGAATATGATTGAAAA CAGCATGTTTGAGGAAGAACCAGATGTGGTGGATTTAGCCAAAGAGCCTTGTTTACATCCTCTAGAGCCTGATGAGGTGGAATATGAGCC CCGGGGTTCCCGACTGCTGGTGCGGGGTCTTGGTGAGCATGAGATGGAGGAGGATGAAGAGGATTATGAGTCATCAGCAAAGCTGCTGGG CATGTCCTTCATGAATAGAAGCTCAGGCCTTCGGAACAGTGCAACTGGTTACAGGCAGAGCCCAGATGGGGCTTGTTCAGTACCCTCTGC AAGGACCATGGTGGTCTGTGCTTTTGTCATCGTGGTTGCTGTTTCTGTAATCATGGTGATTTACTTACTGCCCAGATGTACCTTTACCAA AGAAGGCTGCCATAAAAAAAACCAGTCAATTGGACTAATTCAGCCATTTGCAACAAATGGGAAATTGTTTCCATGGGCACAGATCAGGCT TCCCACTGCCGTTGTGCCACTACGCTATGAACTCAGCCTACACCCGAACCTAACCTCGATGACATTCAGGGGTTCTGTGACAATTTCAGT TCAGGCTCTTCAGGTCACATGGAATATCATTCTTCATAGCACAGGTCATAATATTTCAAGAGTGACCTTTATGTCAGCAGTTTCAAGCCA AGAAAAACAAGCTGAGATCCTGGAATATGCATATCATGGACAGATCGCCATTGTTGCCCCCGAAGCCCTTCTAGCAGGGCACAATTATAC GTTGAAGATAGAGTACTCGGCAAATATATCTAGTTCTTATTATGGGTTTTATGGCTTCTCCTACACAGATGAAAGTAATGAGAAAAAGTA CTTTGCAGCAACTCAGTTTGAACCCCTGGCAGCAAGATCTGCTTTTCCTTGTTTTGATGAACCAGCATTTAAAGCCACTTTTATCATCAA GATCATAAGGGATGAGCAATACACCGCTTTATCAAATATGCCTAAGAAGTCATCAGTCGTTCTAGATGATGGACTTGTTCAGGATGAGTT TTCTGAGAGTGTGAAGATGAGCACTTACTTGGTTGCTTTCATTGTGGGAGAGATGAAGAACCTGAGTCAGGACGTAAATGGAACCCTGCT ACAAGTGGACCTTCTAGTGCAGTTGTTCCTAATACCTCATCTCGGAAAAAGAATATAACTAGCAAAACAGAAACGCATGAACACAAAAAA AACACTGGGAAAAAGAAATGAAATCTTAGCAGAAGCTGGAACTTTTTATACTTATAAAAATAGTATGTTCTTATGTTTCTCCTTATGCAT TTATGTGTTCACTTAAAAATGTTTTTAAATCTAAGGTTTTCTTTGTTTATGTTCAGGTAAGGAACTGTTGTCATGATCTGGAAATGTTTA AAACAATGTTTGTTAGCATTCTGTGAGCAGCAAAACTTATAGTGATAAAAATCGATTGTTGTTAATATGATGTTTACCATGTGCACATAG TAATGAAAAGGAACATAAAAGCCCAGCAGGCTCGTACCAAAGTCACAGCAGTAATGCTATGTACTGCAGAGTCTGATGAGCTGGCCTTTG TGCACACTTTTATTTTCATGGGATTGCATCTTAGCTGTTAAAACTTCTAGATTGAAATTTGACAGCCAGGGTTACATATTGGGGACTTTT AAAGTGTCTTTCCAAAGAGATTTCATTAACCGTTTAGATTAGAATATCTTTCCCAATTGTTACAGTGACATATATGCTGCAATATTTAAC AACTGGAGTATTAGCCACATGGGTTATTTTTTCAATCTGTGTTTTGAATTTTTTTATTGTGTGTTATTTAAAATATTACATATGCAGCTG GGAGAACTACACCTTTGTGCACATAGATTTATATATTAATTTGTAGAAAATATTTTCTTTATATATTTCCTTACCATACAAGGTGCCTTG TTCATCAGGAAAACTTTTGTTTTGTATTTTGACAAGAAAGGCACCTTCAGAGTTTCTTTTTAAGTATAGTTGACAAGTGTATAAATGTTA CACTTACTTTCAGAGTTCTTTTTAGATCTAAAGAAGTCAGTTCAAAAATGGAAATCAACAATGTTAGGAGAAATCTGAATTCTGTTAAGT TAGTAAGTATTATGTATAGCATCTGTTTTTAACCATTTCCATTCTTATCCCTAGTGTATCAGTTGATCACACTAAGAAAGCTTAAAGATT GAGCATTTGAAATAAATGCTCTTTATAAATGATTAGATTTTTGAAGGGATATTGAAATCATTGCGCTGTGATTTCATCTGTGATGTGAAA AATCAATTTATTATCCTTGGTGCTTTCCCCCCCACCAATGCACAAATAATTGTGAACAGCTTGAAATGACTTAAACTGTAATCCAAATGG GACAATCTGATAAGAATTTCATGCATTGGTAGTTAAATAACTTAAATTGCTAAAGCTTTAGCTTGAAATTTATGTTTAGAAAAACTATTG ATTTCCCATGGTATGAATATAACTATTGTAATTCTTCAAATGAGACTCTTCTCACCTTAAATAGTCATATATTAATTAACTTATAGGAAA TAAGCATACTATATGTTAGCTGTTTTAAAAGGTACCAGATGTAAGAGTCATAAATATATGCAATTAAAGAAGTTCATAGATTTCACATGA ATGTAAATGTGTTATATGGAGACATGTCTTGTAAACAGTTGAATGTATGTAAGTTTTCTGTTTGTGAAAATGTAGTTAATGTACTCACTG >45868_45868_4_LNPEP-PPIP5K2_LNPEP_chr5_96322374_ENST00000395770_PPIP5K2_chr5_102537223_ENST00000358359_length(amino acids)=422AA_BP=403 MGRIHFLHFFGFWRSSTFLGSWPCSFIFKATKDRLQLPRNMIENSMFEEEPDVVDLAKEPCLHPLEPDEVEYEPRGSRLLVRGLGEHEME EDEEDYESSAKLLGMSFMNRSSGLRNSATGYRQSPDGACSVPSARTMVVCAFVIVVAVSVIMVIYLLPRCTFTKEGCHKKNQSIGLIQPF ATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIA IVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for LNPEP-PPIP5K2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for LNPEP-PPIP5K2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for LNPEP-PPIP5K2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |